Global Immuno-Oncology Market By Therapy, (Immune Checkpoint Inhibitors, Monoclonal Antibodies (mAbs), Cell & Gene Therapies, Cancer Vaccines, Oncolytic Virus Therapy, Combination Therapies), By Indication (Solid Tumours, Hematologic Malignancies), By Stage/ Line of Therapy (First-line (frontline), Second-line, Third-line/later lines, Adjuvant (post-surgery), Neoadjuvant (pre-surgery)), By Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview Global Immuno-Oncology Market size is expected to be worth around US$ 96.84 Billion by 2034 from US$ 416.28 Billion in 2024, growing at a CAGR of 15.7% during the for...
